Aaron Rosenberg
Vermögen: 6 Mio $ am 28.02.2026
Vermögen: 6 Mio $ am 28.02.2026
Aaron Rosenberg currently works at ArQule, Inc., as Treasurer, Director & Senior Vice President, Acceleron Pharma, Inc., as Treasurer, Director & Senior Vice President from 2021, Harrisvaccines LLC, as Treasurer & Director, Imago BioSciences, Inc., as Treasurer, Director & Senior Vice President from 2023, Prometheus Biosciences, Inc., as Director from 2023, and BeOne Medicines Ltd., as Chief Financial Officer from 2024.
Mr. Rosenberg also formerly worked at Merck & Co., Inc., as Treasurer & Senior Vice President from 2021 to 2024.
Mr. Rosenberg received his Masters Business Admin degree from The Leonard N Stern School of Business and undergraduate degree from Warrington College of Business Administration.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0,01 % | 10.06.2025 | 230.802 ( 0,01 % ) | 6 Mio $ | 28.02.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BEIGENE LTD | Finanzdirektor/CFO | 22.07.2024 |
| ARQULE, INC. | Direktor/Vorstandsmitglied | - |
| ACCELERON PHARMA INC. | Direktor/Vorstandsmitglied | 19.11.2021 |
| IMAGO BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 11.01.2023 |
| PROMETHEUS BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 16.06.2023 |
Harrisvaccines LLC
Harrisvaccines LLC BiotechnologyHealth Technology Develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Treasurer | 01.07.2024 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Harrisvaccines LLC
Harrisvaccines LLC BiotechnologyHealth Technology Develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warrington College of Business Administration
Warrington College of Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imago BioSciences, Inc.
Imago BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops lysine-specific demethylase 1 inhibitors | Health Technology |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition